Skip to main content
Log in
Home
All Courses
Spotlight Sessions
Spotlight Sessions
Summary
Course
Credit Activity Report
PARS log
More
Course info
Conferences and Meetings
Spotlight Sessions
Spotlight Sessions
Category:
Conferences and Meetings
Short name:
2023 AM Education Program-Spotlight Sessions
Course start date:
01/19/2026
Enroll me
Sections
General
0 activities
Spotlight Sessions
0 activities
Advances in Genomics: Tools Finally Opening the Molecular Secrets of Burkitt Lymphoma
3 activities
Advances in Genomics: Tools Finally Opening the Molecular Secrets of Burkitt Lymphoma
Ludmila Prokunina-Olsson-24831
Ryan Morin-24831
Debate: PCC or Andexanet alfa for Managing Bleeding in Patients on Oral Xa Inhibitors?
4 activities
Debate: PCC or Andexanet alfa for Managing Bleeding in Patients on Oral Xa Inhibitors?
Sam Schulman-24130
Deborah Siegal-24130
Deborah Siegal-24152
Immunometabolism as a Tool to Advance Cell Therapy
1 activities
Immunometabolism as a Tool to Advance Cell Therapy
Managing Previvorship in Hematology: Clinical Approaches to CCUS and MBL
3 activities
Managing Previvorship in Hematology: Clinical Approaches to CCUS and MBL
Zhuoer Xie-24131
Paolo Ghia-24131
Tackling Greater Burden of Multiple Myeloma in African American Patients.
4 activities
Tackling Greater Burden of Multiple Myeloma in African American Patients.
Srinivas Devarakonda-24155
Srinivas Devarakonda-24830
Yvonne Efebera-24830
The Mysteries of Factor XI
3 activities
The Mysteries of Factor XI
David Gailani-24832
Ophira Salomon-24832
What is a “Normal” Neutrophil Count? The Duffy Red Cell Antigen, Ancestry, Genetics and Evolution
3 activities
What is a “Normal” Neutrophil Count? The Duffy Red Cell Antigen, Ancestry, Genetics and Evolution
Lauren Merz-24128
John Mark Sloan-24128
Where the Bench Meets the Bedside: Laboratory Correlates in Clinical Trials
3 activities
Where the Bench Meets the Bedside: Laboratory Correlates in Clinical Trials
Justin Taylor-24132
Valeria Santini-24132
Who are the Alternatives for Cellular Therapies? Engineering and Retargeting Other Effector Lymphocytes
3 activities
Who are the Alternatives for Cellular Therapies? Engineering and Retargeting Other Effector Lymphocytes
Carlos Ramos-24129
Jonathan Fisher-24129
Mediasite Content
9
File
18
Enroll me
Loading...
Help
Loading...
Accessibility
Text size
A-
A
A+
Color Adjustments
Monochrome
Low Saturation
High Saturation
High Contrast
Invert Colors
Change Hue
Reset Color Adjustments